Abstract:This study confirms that financial and market data have a significant impact on the valuation of newly listed companies, especially in the biopharmaceutical industry. Using multiple linear regression models, this paper found significant differences in the impact of EBITGR and EBITDAGR on price-to-earnings ratio (P/E Ratio) across years. Other indicators such as Total Asset Turnover, Return on Assets (ROA) and Debt to Equity Ratio (D/E Ratio) have weaker explanatory power and unstable influence. In addition, fluctuations in market valuations of listed companies are influenced by market sentiment and the macroeconomic policy environment. In high-growth, high-risk industries such as biopharmaceuticals, regulatory policies and listing structure reforms in the market can cause structural changes in model performance. At the same time, changes in market sentiment and regulation can also affect the explanatory power of financial indicators to some extent. Further analyses showed that market preferences for valuation changed over time during the study period, especially when the market moved significantly, driven by regulatory policy and the external environment. This makes the conclusions of the study's findings subject to uncertainty in different market environments. Overall, this study reveals a number of key factors affecting the market valuation of newly listed companies and highlights the importance of the interaction between market data and financial indicators. In future research, more attention should be paid to the role of different time periods, market conditions and industry characteristics to avoid potential valuation traps and provide more informative support to market investors and managers.

Research on Multiple Linear Regression of Stock Investment Value based on the Empirical Analysis of the A-share Pharmaceutical Industry in Shanghai and Shenzhen Stock Markets

An Empirical Analysis of Shanghai Stock Market in Using a Modified Functional Coefficient Autoregressive Model Method

Research on the valuation of City Enterprises Based on ARIMA series prediction

On the Usefulness of Financial Ratios in Stock Market Investment Decision-making:An Empirical Study Based on Chinese Security Markets

Stock price analysis based on the research of multiple linear regression macroeconomic variables

Statistical Analysis of the Model of Multi-factors CAPM

The Application of ARIMA and Mean-variance Models on Financial Market

The Combined Effects of Financial and Market Indicators on the Valuation of New Listings: Evidence from the Biopharmaceutical Sector

A Study of Stock Returns in China's A-share Market Based on the Fama-French Three-factor Model

Stock Price Forecast based on ARIMA Model-Taking Yowant Technology and New Oriental Online as Examples

Research on financial early warning of listed companies based on factor analysis and logistic regression

The Applicability of Fama-French Three-factor Model to Beijing Stock Market

Research on the Investment Value of Growth Enterprise Market Stocks in China

An Empirical Study of Capital Asset Pricing Model based on Chinese A-share Trading Data

Risk and Characteristics Factors in China's A-share Stock Returns

Common institutional investors and the quality of management earnings forecasts-Empirical and machine learning evidences

An Empirical Study of Investment Value of Stock Analysis

Research on stock valuation of listed companies and influencing factors of stock price profitability

Fundamental Multi-Factor Stock Selection Strategy Research - Taking the Constituents of the Shanghai and Shenzhen 300 Index as an Example

On the Cross-Sectional Risk Premium of Chinese Stock Market

Research on the Prediction of A-Share “High Stock Dividend” Phenomenon—A Feature Adaptive Improved Multi-Layers Ensemble Model